Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ALBT
ALBT logo

ALBT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Avalon Globocare Corp (ALBT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.290
1 Day change
3.57%
52 Week Range
4.740
Analysis Updated At
2026/06/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ALBT is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock shows weak technical structure, no supportive proprietary buy signal, no recent news catalyst, and no meaningful evidence of improving fundamentals. Based on the data provided, the clear choice is to avoid buying and instead stay out or sell if already held.

Technical Analysis

Current price is 0.303 after a 7.12% regular-session decline, with only a small pre-market and post-market bounce. The trend remains bearish because SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. MACD histogram is slightly positive but contracting, so momentum is not strong enough to reverse the trend. RSI_6 at 32.587 is near oversold but still in a neutral-to-weak zone, not a reliable buy trigger. Price is sitting just above S1 at 0.298 and below the pivot at 0.336, which suggests weak short-term structure and limited confirmation of a rebound. The stock trend model also implies downside pressure near term.

Positive Catalysts

  • No news in the recent week, so there are no clear event-driven upside catalysts. The only minor positive is that the price is slightly above the first support level at 0.298 and the MACD histogram is above zero, but these are weak signals rather than strong catalysts.

Neutral/Negative Catalysts

  • Regular market performance was sharply negative at -7.12%. There is no recent news flow, no strong hedge fund or insider accumulation, no recent congress trading data, and no valuation data to support a bullish thesis. The proprietary signals show no AI Stock Picker signal and no recent SwingMax signal, which removes two important buy triggers. Similar-pattern trend data points to weakness over the next day and limited upside conviction over the next week.

Financial Performance

Latest quarter financials were not available because the financial snapshot returned an error, so there is no usable quarterly revenue or earnings trend to support a buy decision. As a result, there is no evidence of recent fundamental growth acceleration or improving quarterly performance.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target update data was provided, so there is no positive Wall Street revisions trend to highlight. With no analyst upgrades, no price target increases, and no supporting news or fundamentals, Wall Street sentiment cannot be described as favorable. Pro view: the stock is too weak and lacks confirmation. Con view: bearish trend, no catalysts, and no buy signal.

Wall Street analysts forecast ALBT stock price to rise
Analyst Rating
0
Wall Street analysts forecast ALBT stock price to rise
Buy
Hold
Sell
0
Current: 0.291
sliders
Low
0
Averages
0
High
0
0
Current: 0.291
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch